Kim TJ - Search Results

1

nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.

Ahn JH, Lee HS, Lee JS, Lee YS, Park JL, Kim SY, Hwang JA, Kunkeaw N, Jung SY, Kim TJ, Lee KS, Jeon SH, Lee I, Johnson BH, Choi JH, Lee YS. Ahn JH, et al. Among authors: kim sy, kim tj. Nat Commun. 2018 Mar 21;9(1):1166. doi: 10.1038/s41467-018-03556-7. Nat Commun. 2018. PMID: 29563500 Free PMC article.

2

Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.

Yang YI, Lee KT, Park HJ, Kim TJ, Choi YS, Shih IeM, Choi JH. Yang YI, et al. Among authors: kim tj. Carcinogenesis. 2012 Dec;33(12):2488-98. doi: 10.1093/carcin/bgs302. Epub 2012 Oct 1. Carcinogenesis. 2012. PMID: 23027625

3

Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.

Lee J, An S, Choi YM, Lee J, Ahn KJ, Lee JH, Kim TJ, An IS, Bae S. Lee J, et al. Among authors: kim tj. Int J Oncol. 2016 Nov;49(5):1945-1952. doi: 10.3892/ijo.2016.3683. Epub 2016 Sep 6. Int J Oncol. 2016. PMID: 27600258

4

CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer.

Koo YJ, Kim TJ, Min KJ, So KA, Jung US, Hong JH. Koo YJ, et al. Among authors: kim tj. Tumour Biol. 2017 May;39(5):1010428317706226. doi: 10.1177/1010428317706226. Tumour Biol. 2017. PMID: 28488542 Free article.

5

Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells.

Ahn JH, Kim TJ, Lee JH, Choi JH. Ahn JH, et al. Among authors: kim tj. Sci Rep. 2017 Aug 22;7(1):9076. doi: 10.1038/s41598-017-08880-4. Sci Rep. 2017. PMID: 28831167 Free PMC article.

6

Author Correction: Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells.

Ahn JH, Kim TJ, Lee JH, Choi JH. Ahn JH, et al. Among authors: kim tj. Sci Rep. 2018 Jul 18;8(1):11032. doi: 10.1038/s41598-018-29327-4. Sci Rep. 2018. PMID: 30022041 Free PMC article.

7

Author Correction: nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.

Ahn JH, Lee HS, Lee JS, Lee YS, Park JL, Kim SY, Hwang JA, Kunkeaw N, Jung SY, Kim TJ, Lee KS, Jeon SH, Lee I, Johnson BH, Choi JH, Lee YS. Ahn JH, et al. Among authors: kim sy, kim tj. Nat Commun. 2018 Dec 19;9(1):5458. doi: 10.1038/s41467-018-07818-2. Nat Commun. 2018. PMID: 30568190 Free PMC article.

8

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Thaker PH, et al. Among authors: kim tj. Nat Med. 2006 Aug;12(8):939-44. doi: 10.1038/nm1447. Epub 2006 Jul 23. Nat Med. 2006. PMID: 16862152

9

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK. Landen CN, et al. Among authors: kim tj. Neoplasia. 2008 Nov;10(11):1259-67. doi: 10.1593/neo.08740. Neoplasia. 2008. PMID: 18953435 Free PMC article.

10

Ovarian cancer during pregnancy: clinical and pregnancy outcome.

Kwon YS, Mok JE, Lim KT, Lee IH, Kim TJ, Lee KH, Shim JU. Kwon YS, et al. Among authors: kim tj. J Korean Med Sci. 2010 Feb;25(2):230-4. doi: 10.3346/jkms.2010.25.2.230. Epub 2010 Jan 22. J Korean Med Sci. 2010. PMID: 20119575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,111 results

Search Page

Filters